[Synthesis and structure-activity relationship of 13-hexylberberine analogues as CD36 antagonists].
Yinghong Li(Chongqing University of Posts and Telecommunications), Danqing Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Bin Na Hong(Sungkyunkwan University), Yanni Xu, Shuyi Si(Chinese Academy of Medical Sciences & Peking Union Medical College), Li Wang(Nantong University), Jian‐Dong Jiang(Ningbo University)
PubMed
September 1, 2010
Cited by 3
Related Papers
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
|Nature Cancer|2020|880
Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics
|Nucleic Acids Research|2019|830
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics
|Nucleic Acids Research|2017|551
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
NOREVA: normalization and evaluation of MS-based metabolomics data
|Nucleic Acids Research|2017|362